Ordinary Index Rebalancing in the Medical Care Growth Index | February 2022

In the ordinary rebalance the following composition will be implemented effective open 03.02.2022:

ADVERUM BIOTECHNOLOGIES INC
ALECTOR INC
APELLIS PHARMACEUTICALS INC
ATHERSYS INC
AVEO PHARMACEUTICALS INC
AVID BIOSERVICES INC
BEAM THERAPEUTICS INC
BIOCRYST PHARMACEUTICALS INC
BIOHAVEN PHARMACEUTICAL HOLD
BIOLIFE SOLUTIONS INC
CO-DIAGNOSTICS INC
DECIPHERA PHARMACEUTICALS INC
DYNAVAX TECHNOLOGIES CORP
FULGENT GENETICS INC
GRITSTONE BIO INC
HALOZYME THERAPEUTICS INC
HARMONY BIOSCIENCES HOLDINGS INC
INARI MEDICAL INC
INOTIV INC
INTRA-CELLULAR THERAPIES INC
LA JOLLA PHARMACEUTICAL CO
LINEAGE CELL THERAPEUTICS INC
MARINUS PHARMACEUTICALS INC
MESA LABORATORIES INC
MIRATI THERAPEUTICS INC
MODERNA INC
OCULAR THERAPEUTIX INC
ONCOCYTE CORP
PARATEK PHARMACEUTICALS INC
PENUMBRA INC
PFIZER INC
PHASEBIO PHARMACEUTICALS INC
REPLIGEN CORP
SAGE THERAPEUTICS INC
SELECTA BIOSCIENCES INC
SHOCKWAVE MEDICAL INC
STAAR SURGICAL CO
SYNDAX PHARMACEUTICALS INC
TANDEM DIABETES CARE INC
UROGEN PHARMA LTD
VIR BIOTECHNOLOGY INC
XERIS BIOPHARMA HOLDINGS INC
ZOGENIX INC